CLNN - Clene Inc.
4.54
0.140 3.084%
Share volume: 39,404
Last Updated: 03-11-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$4.40
0.14
0.03%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-08-2024 | 08-14-2023 | 11-07-2023 | 11-13-2024 | 05-08-2024 | 08-07-2024 | 11-13-2024 | |
| Assets | ||||||||
| Total Assets | 39.888 M | 67.845 M | 60.433 M | 52.341 M | 45.069 M | 40.330 M | 31.569 M | |
| Current Assets | 24.822 M | 53.371 M | 46.446 M | 38.852 M | 32.111 M | 27.910 M | 19.698 M | |
| Inventories | 88.000 K | 52.000 K | 104.000 K | 37.000 K | 37.000 K | 37.000 K | 128.000 K | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 6.179 M | 6.178 M | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 18.442 M | 49.243 M | 42.113 M | 28.821 M | 21.732 M | 21.682 M | 14.645 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 10.514 M | 10.033 M | 9.642 M | 9.263 M | 8.854 M | 8.442 M | 8.037 M | |
| Other Assets | 4.552 M | 4.441 M | 4.345 M | 4.226 M | 4.104 M | 3.978 M | 3.834 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 39.888 M | 67.845 M | 60.433 M | 52.341 M | 45.069 M | 40.330 M | 31.569 M | |
| Total liabilities | 41.515 M | 46.312 M | 39.027 M | 38.951 M | 40.805 M | 40.834 M | 35.694 M | |
| Total current liabilities | 16.876 M | 5.735 M | 15.268 M | 25.330 M | 26.185 M | 28.069 M | 23.828 M | |
| Accounts Payable | 608.000 K | 846.000 K | 1.889 M | 1.504 M | 1.645 M | 1.066 M | 1.678 M | |
| Other liabilities | 2.617 M | 14.738 M | 2.029 M | 6.469 M | 2.815 M | 5.752 M | 592.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 16.620 M | 25.839 M | 16.650 M | 7.152 M | 7.085 M | 7.013 M | 6.939 M | |
| Other liabilities | 2.617 M | 14.738 M | 2.029 M | 6.469 M | 2.815 M | 5.752 M | 592.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -1.627 M | 21.533 M | 21.406 M | 13.390 M | 4.264 M | -504.000 K | -4.125 M | |
| Common stock | 203.141 M | 251.491 M | 253.867 M | 255.914 M | 257.927 M | 259.914 M | 264.226 M | |
| Retained earnings | -204.989 M | -230.132 M | -232.550 M | -242.723 M | -253.803 M | -260.588 M | -268.574 M |